328087-58-7

Upstream product

• 14385-63-8 3-furan-2-yl-1-p-tolyl-propenone 
• 109-77-3 malononitrile 

Downstream Products

• 329190-06-9 5-furan-2-yl-4-imino-3-(2-methoxy-phenyl)-7-p-tolyl-3,4-dihydro-1H-pyrido[2,3-d]pyrimidine-2-thione 
• 400031-55-2 2-amino-4-furan-2-yl-6-p-tolyl-nicotinamide 
• 400031-80-3 5-furan-2-yl-3-(2-methoxy-phenyl)-2-thioxo-7-p-tolyl-2,3-dihydro-1H-pyrido[2,3-d]pyrimidin-4-one 
• 328087-62-3 4-amino-5-furan-2-yl-7-p-tolyl-1H-pyrido[2,3-d]pyrimidine-2-thione 

Relevant academic research and scientific papers

Synthesis of some 2-thioxopyrido[2,3-d]pyrimidine ribofuranosides and their antimicrobial activity

2-Thioxo-3,5,7-trisubstituted-1-[2′,3′.5′-tri-O-benzoyl-β -D-ribofuranosyl]pyrido[2,3-d]pyri midin-4(IH)-ones have been prepared by the condensation of trimethylsilyl derivative of 2-thioxo-3,5,7-trisubstituted pyrido[2,3-d]pyrimidin-4(IH)-ones with β-D-ribofuranose 1-acetate-2,3,5-tribenzoate in 65%-78% yield. The structure of the synthesized ribofuranosides and their precursors have been established by IR. 1H NMR and elemental analysis. These derivatives have been screened for their antimicrobial activity.

Synthesis and antimicrobial evaluation of some new pyrido[2, 3-d]pyrimidines and their ribofuranosides

4-Amino-5, 7-disubstituted 3- d] pyrimidin-2(1 H)-ones 3 and 5, 7-disubstituted-pyrido[2.3-d]-pyrimidine-2-4-(1H, 2H dithiones 4 have been synthesized by the condensation of 2-amino-3-cyano-4, 6-disubstituted-pyridines 2 with urea and carbon disulphide, respectively. Compounds 2 have been synthesized by condensing chalcones 1 with malononitrile and ammonium acetate. The condensation of trimethylsilyl derivatives of compounds 3 with β-D-ribofuranose 1-acetate-2, 3, 5-tribenzoate in the presence of SnCl4 furnish the nucleosides, viz, 4-amino-5, 7-disubstituted-1-(2, 3, 5-tri-O-benzoyl-α-D-ribofuranosyl)pyrido[2, 3-d]pyrimidin-2(1H)-ones 5. Compounds 3-5 have been screened for their antibacterial and antifungal activities.

Synthesis of some new pyrido[2,3-d]pyrimidines and their ribofuranosides as possible antimicrobial agents

The ribofuranosides, namely, 4-amino-5,7-disubstituted-1-[2′,3′,5′- tri-O-benzoyl-α-D-ribofuranosyl]pyrido-[2,3-d] pyrimidine-2(1H)-thiones, have been synthesized by the condensation of trimethylsilyl derivatives of 5,7-disubstituted pyrido[2,3-d]pyrimidine-2(1H)-thiones with β-D-ribofuranose-1-acetate-2,3,5-tribenzoate in the presence of SnCl4. The heterocyclic bases, namely, 4-amino-5,7-disubstituted pyrido[2,3-d]pyrimidine-2(1H)-thiones, were synthesized by the treatment of 2-amino-3-cyano-4,6-disubstituted pyridines with thiourea. The structures of all the synthesized ribofuranosides and their precursors have been established by elemental analysis, IR, and 1H NMR spectral data. The 13C NMR data of ribofuranosides has also been presented. All the synthesized heterocyclic bases and their ribofuranosides have been screened for their antibacterial and antifungal activities.

Synthesis of some novel 4-imino-3,5,7-trisubstituted pyrido[2,3-d]pyrimidine-2(1H)-thiones and their nucleosides as potential therapeutic agents

Some newer 4-imino-3,5,7-trisubstituted pyrido[2,3-d]pyrimidine-2(1H)-thiones were synthesized by the condensation of 2-amino-3-cyano-4,6-disubstituted pyridines with phenylisothiocyanate. The nucleosides viz., 4-imino-3,5,7-trisubstituted-1-(2,3,5-tri-O-